|
|
News Breaks
|
February 8, 2012
|
| 18:41 EDT |  | IRWD, FRX |
| theflyonthewall.com: | Ironwood Pharmaceuticals: No FDA advisory meeting for NDA of Linaclotide | | Ironwood Pharmaceuticals (IRWD) announced that it was informed this evening that the U.S. FDA will not schedule an advisory committee meeting in connection with the its review of the New Drug Application for linaclotide proposed for the treatment of irritable bowel syndrome with constipation and chronic constipation. On August 9, 2011, Ironwood, along with its partner Forest Laboratories (FRX), announced that they submitted the NDA for linaclotide to the FDA. Under the FDA's Prescription Drug User Fee Act, the companies anticipate action by the FDA in June, approximately 10 months from the submission date. :theflyonthewall.com |
|
|
News For IRWD;FRX From The Last 14 Days Check below for free stories on IRWD;FRX the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 21, 2012
|
| 14:18 EDT |  | IRWD |
|
|
May 15, 2012
|
| 10:14 EDT |  | IRWD |
|
|
May 14, 2012
|
| 16:09 EDT | | IRWD |
| theflyonthewall.com: | Ironwood Pharmaceuticals initiated with a Hold at Jefferies | | Target $13. :theflyonthewall.com |
|
|
|
|
|
Subscribe for More Information